This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hibi, Y. Articles by Seo, H. Search for Related Content PubMed PubMed Citation Articles by Hibi, Y. Articles by Seo, H. Related Collections Calcium and Bone Metabolism Endocrine Oncology

Up-Regulation of the Gene Encoding Protein Kinase A Type I Regulatory Subunit in Nodular Hyperplasia of Parathyroid Glands in Patients with Chronic Renal Failure

Department of Endocrinology and Metabolism, Division of Molecular and Cellular Adaptation, Research Institute of Environmental Medicine, Nagoya University (Y.H., F.K., H.S.), Nagoya 464-8601, Japan; Department of Surgery, Renal Center, Nagoya Second Red Cross Hospital (Y.T.), Nagoya 466-8650, Japan; Department of Breast and Endocrine Surgery, Nagoya University Hospital (Y.H., Y.M., H.K., T.I.), Nagoya 466-8560, Japan; and Department of Endocrine Surgery, Fujita-Health University School of Medicine (K.I.), Toyoake 470-1192, Japan

Address all correspondence and requests for reprints to: Dr. Fukushi Kambe, Department of Endocrinology and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. E-mail: kambe{at}riem.nagoya-u.ac.jp.

Context: Hyperplasia of parathyroid glands in patients with chronic renal failure is classified into diffuse (DH) and nodular (NH) types, and NH is often refractory to routine medical therapy.

Objective: Although it is considered that the parenchymal cells initially proliferate diffusely and then some of them are transformed to form nodules consisting of monoclonal cells, the underlying molecular mechanism for such a transformation is not fully understood. In this study we tried to identify the genes that are up-regulated in NH.

Design and Setting: The cDNA population prepared from DH was subtracted from that prepared from NH by a PCR-based cDNA subtraction method. The resultant cDNAs were cloned and sequenced. To confirm the up-regulation of the identified genes, a total of 35 parathyroid glands (18 DH, 16 NH, and one mixed) obtained from 21 patients were analyzed.

Results: One of the nuclear genes identified was the PRKAR1A gene, which encodes type I regulatory subunit (RI) of cAMP-dependent protein kinase (PKA). Immunohistochemical analysis demonstrated that RI was abundantly expressed in the nodular region, whereas the adjacent diffuse region displayed relatively low expression. Northern and Western blot analyses demonstrated up-regulation of RI expression in most NH tested. Determination of PKA activities revealed that free PKA activities measured in the absence of cAMP in the assay were inversely correlated with RI expression, indicating the functional significance of RI up-regulation.

Conclusions: These results suggest that the aberrant expression of RI is involved in the diffuse to nodular transformation of hyperplasia of parathyroid glands by impairing cAMP/PKA signal transduction.